ADVERTISEMENT
Poster
2758073
A Focus on Functional Recovery in MDD: Patient-Centered Strategies to Address Residual Symptoms and Treatment-Emergent Adverse Effects
A variety of multimodal treatments that can address the spectrum of MDD symptom domains and ongoing management challenges, including residual symptoms and treatment-emergent adverse effects (TEAEs) have emerged that may address unmet needs in MDD pharmacotherapy. These newer agents feature improved tolerability profiles that may help to mitigate the treatment-emergent sexual dysfunction, weight gain, cognitive dysfunction, and emotional blunting associated with other antidepressant medications. Because adequately treating MDD—including mitigating residual symptoms and TEAEs—is essential for optimizing patient outcomes, it is imperative that psychiatry clinicians are prepared to refine their approach to MDD and are equipped with evidence-based strategies to assess symptoms and, utilizing patient-centered and shared decision-making strategies, select personalized therapies best attuned to patients’ individual needs.
Sign Up
Psych Congress Network Newsletter
